Brief: Novavax Says EMA Approves SK Bioscience As A Supplier Of Novavax Nuvaxovid Covid-19 Vaccine
07/07/2022 13:48
July 7 (Reuters) - Novavax Inc NVAX.O :
* NOVAVAX SAYS EUROPEAN MEDICINES AGENCY APPROVES SK
BIOSCIENCE AS
A SUPPLIER OF NOVAVAX NUVAXOVID COVID-19 VACCINE
Source text: https://bit.ly/3O3P9RT
Further company coverage: 302440.KS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SK Bioscience Co
See all newsBrief: SK Bioscience Joins Forces With Global Institutions To Advance Rotavirus Vaccine Development
Brief: SK Bioscience Files For First-In-Human Trial Of Universal Coronavirus Vaccine GBP511 Phase 1/2 Study In Australia
Novavax beats quarterly revenue estimates on milestone payment (updated)
Brief: Sk Bioscience Submits Ind For Phase 1/2 Clinical Trial Of Adjuvanted Influenza Vaccine Candidate
Brief: SK Bioscience - Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine